In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Meet the Team

Lucie Ellis

Lucie Ellis

Executive Editor 
Lucie.Ellis@informa.com

@ScripLucie

Lucie has been covering the ups and downs of the pharmaceutical industry since joining the Informa Pharma Intelligence team in 2012. Prior to being Managing Editor of In Vivo, Lucie was a Senior Editor at Scrip and Pink Sheet. She is responsible for the production of In Vivo’s print and online editions and also contributes feature-length articles to the publication on the topics of leadership, R&D, innovation and more.

Read more »


Ben Comer

Pharma Editor 
Ben.Comer@informa.com

@BenMComer

Ben is Pharma Editor at In Vivo, responsible for biopharma industry coverage. His areas of focus include commercialization and R&D strategy, regulation, policy and social issues impacting the sector. Prior to joining In Vivo, Ben was a Senior Manager at PwC’s Health Research Institute and a Senior Editor at Pharmaceutical Executive magazine.

Read more »


Ashley Yeo

Medtech Editor
ashley.yeo@informa.com

@ashleypyeo

Ashley Yeo delivers content that gives insight into current and future trends in the global medtech industry, and what players need to do, and with whom, to keep ahead of the game in this fast-evolving and highly competitive sector. He currently writes for In Vivo and Medtech Insight as an Executive Editor. Ashley has been with Informa and legacy publications, reporting on all forms of healthcare (plant, animal, human) for over 30 years, having joined as a linguist on the European desk and later becoming editor of three diverse publications. He has also contributed aesthetic medicine and pharma content when a member of the multifunctional team of pharma analysts. His current focus is the strategic rationale of the big players in medtech, on In Vivo; and UK, European and OUS global regulation and policy input on Medtech Insight..

Read more »


 Amanda Micklus

 

Amanda Micklus

Principal Analyst
amanda.micklus@informa.com

@amandamicklus

Amanda has been tracking corporate strategy and business development activities in the biopharma and medtech industries for more than 10 years. She is a principal analyst with Informa’s Datamonitor Healthcare where she researches and analyzes trends in corporate strategy and dealmaking, and compiles reports for clients. Amanda also writes trends pieces for Informa’s IN VIVO and START-UP publications, and contributes to Informa’s Strategic Transactions deals database, researching and writing analyses on individual biopharma and medtech transactions. Before joining Informa, Amanda spent five years at Purdue Pharma, working as a market research analyst and information searcher. She has a Bachelor of Science degree in Chemistry-Business from the University of Scranton, and a Master of Science in Library & Information Science from Long Island University.

Read more »


 

 

Karen Coleman

Head of Editorial Ops
karen.coleman@informa.com

Karen is the Head of Editorial Operations for In Vivo, Pink Sheet and Scrip working with a global team of expert, experienced and respected journalists. She qualified as a pharmacist in South Africa in 2000 where she worked in retail and hospital settings before relocating to the UK in 2002. Karen spent nine months working for the NHS in a variety of hospital pharmacy settings, including Moorfields Eye Hospital. In December 2002 she joined IMS Health (now IQVIA), analyzing patent expiries and generic drug launches in 26 major and emerging markets. Karen joined Informa in 2009, leading a team of analysts publishing Strategic reports covering numerous aspects of the Pharma and Medtech industries. She has held a number of management and leadership roles over the years, ensuring the successful delivery of product enhancements and consolidation, and process improvements, working closely with Editorial, Technical and Commercial teams.

UsernamePublicRestriction

Register